Reuters logo
BRIEF-Tigenix submits day 120 responses to EMA for CX601 marketing authorization
December 22, 2016 / 9:18 PM / a year ago

BRIEF-Tigenix submits day 120 responses to EMA for CX601 marketing authorization

Dec 22 (Reuters) - Tigenix NV :

* Tigenix NV - Tigenix submits day 120 responses to European Medicines Agency for CX601 marketing authorization

* Tigenix- expects to receive EMA day 180 list of outstanding issues in Feb 2017, anticipates decision from EMA on CX601 marketing approval during 2017

* Tigenix- if approved, would trigger the payment by Takeda to Tigenix of euro 15 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below